A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

NACompletedINTERVENTIONAL
Enrollment

560

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2002

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-n3

DRUG

Interferon alfa-n1

Trial Locations (15)

10031

Dr Barbara Justice, New York

10037

Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York

10595

New York Med College / Westchester County Med Ctr, Valhalla

11203

SUNY / Health Sciences Ctr at Brooklyn, Brooklyn

19104

Univ of Pennsylvania Med Ctr, Philadelphia

19801

Med Ctr of Delaware / Wilmington Hosp, Wilmington

20007

Georgetown Univ Med Ctr, Washington D.C.

20019

Abundant Life Clinic Foundation, Washington D.C.

20059

Howard Univ Hosp, Washington D.C.

37208

Meharry Med College, Nashville

48202

Henry Ford Hosp, Detroit

55455

Univ of Minnesota Hosp, Minneapolis

90059

King - Drew Med Ctr, Los Angeles

94063

AIDS Community Research Consortium, Redwood City

065102483

Yale Univ / New Haven, New Haven

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH